Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

tions (10,024,075) (9,876,760) (33,225,627) (29,652,777)

Interest income 126,655 221,333 481,855 747,921

Interest expense (159,359) (241,735) (528,924) (292,018)

Other income - - 75,000 976,815

Net loss $(10,056,779) $(9,897,162) $(33,197,696) $(28,220,059)

Basic and diluted

net loss per share $(0.22) $(0.33) $(0.78) $(0.93)

Shares used in

calculation of basic

and diluted net

loss per share 46,650,833 30,302,628 42,831,867 30,209,948

MIDDLEBROOK PHARMACEUTICALS, INC.

CONDENSED BALANCE SHEETS

(Unaudited)

September 30, December 31,

2007 2006

ASSETS

Current assets:

Cash and cash equivalents $4,987,690 $14,856,738

Marketable securities 929,812 522,723

Accounts receivable, net 1,331,764 303,514

Inventories, net 1,088,913 2,077,390

Prepaid expenses and other

current assets 1,199,515 1,682,685

Total current assets 9,537,694 19,443,050

Property and equipment, net 11,533,248 11,764,627

Restricted cash 872,180 872,180

Deposits and other assets 348,006 1,548,585

Intangible assets, net 7,509,070 8,377,327

Total assets $29,800,198 $42,005,769

LIABILITIES AND STOCKHOLDERS' EQUITY


'/>"/>
SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... NY (PRWEB) , ... June 30, 2015 , ... New ... New York July 7th and 11th 2015. Timber frame post and beam raisings offer ... , “Raising a timber frame is an important and exciting event ...
(Date:6/30/2015)... Santa Cruz, CA (PRWEB) , ... June 30, ... ... FitAID product is now the official ready-to-drink sponsor of two leading organizations dedicated ... Team Some Assembly Required (SAR). , I AM ADAPTIVE™ is now the official ...
(Date:6/30/2015)... ... June 30, 2015 , ... James C. ... & Sarcoma surgery at HackensackUMC and Director of the Skin and Sarcoma division ... distribution of his online Orthopedic Oncology and Pathology Course. The newly installed ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... has joined Allegheny Health Network (AHN) as Director of its Adult ... management of primary brain tumors, brain metastases, leptomeningeal disease and the neurological complications ...
(Date:6/30/2015)... ... June 30, 2015 , ... Eldermark Software shakes up the ... senior care sector. As an innovator of senior care software products, ... efficient and offer residents better care. , This next-generation interactive system handles all ...
Breaking Medicine News(10 mins):Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3
... their skins, but some restaurants and population groups also want ... animals can have side effects that call into question the ... and to a lesser extent contamination from heavy metals and ... problems to health. This is the conclusion of a study ...
... Problem-Riddled Health Freedom Act Could See Idaho Lose $1.6 Billion ... Idaho , Feb. 9 As the Idaho House ... health care law, the long-term effects of the move could be ... Freedom Act (House Bill 391) a disastrous and problem-riddled piece of ...
... Mich.- Michigan State University has launched the nation,s first ... counterfeiting- which the FBI has called "the crime of ... pharmaceuticals to food additives to auto parts- accounts for ... has a major impact on health and safety, the ...
... infants born prematurely in the US, according to data ... These findings were reported at the 30th Annual Meeting ... also were published in the latest issue of the ... Researchers reported that CP is associated with inflammation of ...
... YORK , Feb. 9 The following is a ... the childhood obesity epidemic will require the kind of clear-eyed and ... the First Lady stressed, too many of our children attend schools ... For many black and Latino children, however, that bleak food landscape ...
... of advanced breast cancer diagnosis among black women remained ... women between 1992 and 2004, according to new findings ... addition, the disparity in the incidence of advance colorectal ... fell among whites but increased slightly among blacks. , ...
Cached Medicine News:Health News:Study carried out into biological risks of eating reptiles 2Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:Incidence of cerebral palsy on rise in US 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 4
(Date:6/30/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces the ... StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ET / 2:10 ... onto our website listed above.   If ... a replay of the webcast will be available for ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
(Date:6/29/2015)... 30, 2015 , Gerresheimer will sell ... and Gerresheimer enter into a 10-year-supply agreement for pharmaceutical ... EUR 196m debt-free Corning and Gerresheimer will ... glass packaging market Gerresheimer,s outlook for the financial ... disposal of the tubing business , In line ...
(Date:6/29/2015)... 29, 2015  Nevro Corp. (NYSE: NVRO ), ... evidence-based solutions for the treatment of chronic pain, today ... Executive Officer of Intersect ENT (NASDAQ: XENT ), ... June 28, 2015. For the last ... Intersect ENT, a company dedicated to improving the quality ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... HAIFA, Israel, November 11 Cardio Vascular,Medical ... advanced,cardiovascular surgery technology, today announced the completion of ... . , Cardio Vascular ... innovative,next-generation "steerable guidewire" applicable for all angioplasty (PCTA),procedures. ...
... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for oral ... Access intends to commercially launch MuGard in North America ... pertaining to the launch include: , Manufacturing : ...
Cached Medicine Technology:Cardio Vascular Medical Device Launches Corporate Website 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 4
Shandon Microscope Slide Cabinet with Drawers...
... data from multiple sources is not ... ResultNet/Plus software allows you to concentrate ... communications network., ,ResultNet/Plus eliminates the complexity ... largescale or multi-site laboratories to host ...
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
ACE Control Serum provides the laboratory with vital information on the performance of the ACE chemistry assay....
Medicine Products: